Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review

Current pharmacological treatments for chronic obstructive pulmonary disease (COPD) are mostly limited to inhaled bronchodilators and corticosteroids. Azithromycin can contribute to exacerbation prevention. Roflumilast, a phosphodiesterase (PDE) 4 inhibitor administered orally, also prevents exacerb...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Clémence, Burgel, Pierre-Régis, Roche, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378910/
https://www.ncbi.nlm.nih.gov/pubmed/34429594
http://dx.doi.org/10.2147/COPD.S226688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378910/
https://www.ncbi.nlm.nih.gov/pubmed/34429594
http://dx.doi.org/10.2147/COPD.S226688

Ejemplares similares